A Research Study Investigating Safety and Concentration in the Blood After One Dose Tablet of the New Medicine Monlunabant in Healthy Weight Japanese and Caucasian Men
Clinical trial NCT06542536 · COMPLETED
Trial details
- NCT number
- NCT06542536
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-09
- Primary completion
- 2024-10-25
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.